gm604
Peptideexperimental
Clinical trial activity
1 trials · 3 clinical orgs · 0 marketing orgs
Phase 1
0
Phase 2
1
Phase 3
0
Phase 4
0
Earliest trial started Aug 1, 2013 (NCT01854294)
Timeline
2010s
- Jan 1, 2013
Earliest Phase 2 Sponsor(trial)
Indications
Studied for
Mechanism of action
- Brain-derived neurotrophic factorSupplementation
BDNF supplementation
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Also known as
- gm604
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT01854294 | Phase 2 | Aug 1, 2013 | Columbia University, Genervon Biopharmaceuticals, LLC, Harvard University |
Showing 1 of 1 trials
Page 1 / 1
Organizations
Research & Development (3)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Columbia University | Academic/Hospital | 1 | 0 | 1 | 2013 |
| Genervon Biopharmaceuticals, LLC | For profit | 1 | 1 | 1 | 2013 |
| Harvard University | Academic/Hospital | 1 | 0 | 1 | 2013 |
3 organizations
Page 1 / 1